BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19200609)

  • 1. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
    Chou PC; Chuang TF; Jan TR; Gion HC; Huang YC; Lei HJ; Chen WY; Chu RM
    Vet Immunol Immunopathol; 2009 Jul; 130(1-2):25-34. PubMed ID: 19200609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
    Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
    Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
    Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta 1 and restores the lymphokine-activated killing activity.
    Hsiao YW; Liao KW; Hung SW; Chu RM
    J Immunol; 2004 Feb; 172(3):1508-14. PubMed ID: 14734728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
    Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
    Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
    Hsiao YW; Liao KW; Hung SW; Chu RM
    Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
    Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
    Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid.
    Pai CC; Kuo TF; Mao SJ; Chuang TF; Lin CS; Chu RM
    Vet Immunol Immunopathol; 2011 Feb; 139(2-4):187-99. PubMed ID: 21051091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chicken HSP70 DNA vaccine inhibits tumor growth in a canine cancer model.
    Yu WY; Chuang TF; Guichard C; El-Garch H; Tierny D; Laio AT; Lin CS; Chiou KH; Tsai CL; Liu CH; Li WC; Fischer L; Chu RM
    Vaccine; 2011 Apr; 29(18):3489-500. PubMed ID: 21392590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
    Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model.
    Chang CY; Lee J; Kim EY; Park HJ; Kwon CH; Joh JW; Kim SJ
    BMC Cancer; 2007 May; 7():87. PubMed ID: 17519043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for the treatment of canine transmissible venereal tumor based in dendritic cells pulsed with tumoral exosomes.
    Ramos-Zayas Y; Franco-Molina MA; Hernádez-Granados AJ; Zárate-Triviño DG; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Ramírez-Romero R; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):48-54. PubMed ID: 30334465
    [No Abstract]   [Full Text] [Related]  

  • 13. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
    Zhang C; Zhang J; Niu J; Zhang J; Tian Z
    Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model.
    Chiang HC; Liao AT; Jan TR; Wang YS; Lei HJ; Tsai MH; Chen MF; Lee CY; Lin YC; Chu RM; Lin CS
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):207-16. PubMed ID: 23237908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses: implications for immune function in aged mice.
    Motegi A; Kinoshita M; Inatsu A; Habu Y; Saitoh D; Seki S
    J Leukoc Biol; 2008 Oct; 84(4):1047-56. PubMed ID: 18653461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells.
    Liao KW; Hung SW; Hsiao YW; Bennett M; Chu RM
    Vet Immunol Immunopathol; 2003 May; 92(3-4):149-62. PubMed ID: 12730015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs.
    Morandi B; Mortara L; Carrega P; Cantoni C; Costa G; Accolla RS; Mingari MC; Ferrini S; Moretta L; Ferlazzo G
    Int Immunol; 2009 May; 21(5):599-606. PubMed ID: 19325034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD137 enhances cytotoxicity of CD3(+)CD56(+) cells and their capacities to induce CD4(+) Th1 responses.
    Zhu BQ; Ju SW; Shu YQ
    Biomed Pharmacother; 2009 Aug; 63(7):509-16. PubMed ID: 19019623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.